Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: sds who wrote (1974)	5/7/1998 9:41:00 PM
From: David Bogdanoff	Respond to of 4676

SDS: ENMDs 600% increase was based on false info. Watson of DNA fame was misquoted in predicting a cure for cancer in 2 years; this is clearly stated in the url I posted. I suggest that if anti-sense technology were to be stated as being a cure for cancer by someone of Watson's stature, then we would see a comparable increase, albeit shortlived, for ISIP. Investor actions were irrational because they clearly did not do DD and unreasonably thought that a magic bullet (a safe cure!) had been found (despite decades of dead ends). BTW, I would not expect a Human anti-sense drug to work well in a distantly related mammal because of differences in genetic structure; the technology does involve a mirror image of a dna fragment to put the kabosh on the cancer cell growth machinery. I do admit to being a non-expert on this though, and wellcome comments from technical experts. David